Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).

The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

IMS 2026 | Understanding the patient perspective in multiple myeloma disease management

Jenny Ahlstrom, HealthTree Foundation, South Jordan, UT, shares insights into key, underrecognized aspects of the patient experience, highlighting the importance of a single, patient-owned health record, as patients often have their data scattered across multiple electronic health record portals. She also emphasizes the value of patient participation in research, not only through clinical trials, but also by sharing clinical data and patient-reported outcomes. This interview took place at the 23rd International Myeloma Society (IMS) Annual Meeting in Glasgow, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.